Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
1.050
0.00 (0.00%)
Nov 21, 2024, 1:47 PM EST - Market open
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $79.64 million as of November 21, 2024. Its market cap has increased by 12.64% in one year.
Market Cap
79.64M
Enterprise Value
106.02M
1-Year Change
12.64%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $79.64M, a decrease of -43.92%. That is a compound annual growth rate of -6.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 78.10M | 6.99% |
| Dec 29, 2023 | 73.00M | 8.31% |
| Dec 30, 2022 | 67.40M | -58.93% |
| Dec 31, 2021 | 164.10M | 23.85% |
| Dec 31, 2020 | 132.50M | 11.06% |
| Dec 31, 2019 | 119.30M | 247.81% |
| Dec 31, 2018 | 34.30M | -80.67% |
| Dec 29, 2017 | 177.40M | -3.53% |
| Dec 30, 2016 | 183.90M | 29.51% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 79.76M |
| Chimerix | 79.14M |
| MDxHealth | 78.97M |
| Renovaro | 78.39M |
| OptimizeRx | 77.37M |
| 23andMe Holding Co. | 77.36M |
| Quince Therapeutics | 77.00M |
| Oncolytics Biotech | 76.26M |